Israel invents breath-checking device for identifying diseases

A device was just invented by researchers, which can make out up to 17 different diseases just by analyzing the chemical makeup of a persons breath.

This is the worlds first singular device that can make an authenticated reading of a persons breath and the first to accurately check for a wide array of afflictions with just the one sample already mentioned including but not limited to Parkinsons disease and kidney cancer even.

The team of researchers led by Hossam Haick from the Technion-Israel Institute of technology told foreign media, "Since antiquity (~400 BC), physicians learned to evaluate their patients by exhaled volatile organic compounds (VOCs), among other means, that are linked to diseases. For example, the stools and urine of infant noblemen were smelt daily by their physicians."

However, the team on the up and go digitized the practice by taking it up a notch and making a device that analyses breathprints of various diseases.

The device functions on the basis on different chemical components that we emit when exhaling, there are up to 100 different types of volatile chemical markers that we give off while breathing. Analyzing these markers or breathprints, can lead to the diagnosis of a myriad of sickness in a timely fashion.

Additionally, studying breath is a lot easier than analyzing other bodily fluids. The team says, "Of these body fluids, exhaled breath is the most accessible and useful VOC source for monitoring bodily health and disorder. This is because exhaled breath is easily and noninvasively accessible; it is suitable for high compliance; it provides a matrix of relative low complexity, and it can be handled safely and repeated as frequently as desired."

To make the device, the team created an artificially intelligent nanoarray of highly specialised sensors that could comb through the compounds in a persons breath to see if any of them matched up with VOCs or breathprints that are commonly attributed to different diseases.

They then tested the device on multiple patients - some healthy and some who were already diagnosed with a disease - to see how accurate it was.

"A total of 2,808 breath samples were collected from 1,404 subjects having one of 17 different disease types that had been put into three main categories (cancerous, inflammatory, and neurological diseases) and one group of uncorrelated diseases, as well as a group of healthy controls," the team writes.